AZO vs HAE · P/E 21, rev $18.94B vs P/E 35, rev $1.36B
AutoZone Inc (AZO) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
AZO currently screens at market cap $50.08B and trailing P/E 21.0. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the AZO and HAE stock pages for the full models.
Not investment advice.